Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand.

de Hora, Mark R; Heather, Natasha L; Webster, Dianne R; Albert, Benjamin B; Hofman, Paul L

de Hora, Mark R; Heather, Natasha L; Webster, Dianne R; Albert, Benjamin B; Hofman, Paul L.

Afiliación

de Hora MR; Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital, Auckland 1040, New Zealand.
Heather NL; Liggins Institute, University of Auckland, Auckland 1010, New Zealand.
Webster DR; Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital, Auckland 1040, New Zealand.
Albert BB; Liggins Institute, University of Auckland, Auckland 1010, New Zealand.
Hofman PL; Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital, Auckland 1040, New Zealand.

Int J Neonatal Screen ; 8(4)2022 Oct 21.

Article en En | MEDLINE | ID: mdl-36278626

Palabras clave

21-hydroxylase deficiency; CAH; LCMSMS; congenital adrenal hyperplasia; newborn screening; positive predictive value

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Screening_studies Idioma: En Revista: Int J Neonatal Screen Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google